7 Food Categories From China Face Automatic Detention in US After New FDA Alert
The US FDA has issued a new import alert impacting a broad range of products from a Guangdong-based company, according to the agency’s latest update on July 10, 2025. The action, under Import Alert 99-32, targets Long Fei Foods Co., Ltd. in Shantou, covering seven categories including cereals, ice cream, vegetables, fruits, and meats.
The reason for this automatic detention is the company’s refusal to undergo an FDA inspection. Under the alert, products are subject to Detention Without Physical Examination (DWPE) at US ports. This means shipments are held automatically and can only be released after passing FDA or recognized third-party lab testing, followed by review and approval from the agency’s local branch.
Import alerts are triggered when there are potential safety concerns. While automatic detention does not necessarily mean the goods violate US standards, it places a significant compliance burden on exporters. Affected products must now clear extra hurdles before being allowed into the US market.
Industry insiders warn that exporters should stay vigilant and ensure full cooperation with regulatory authorities to avoid costly delays and reputational risks.
2026-09-06
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
2026 Q1 Chemical Giant Earnings: Supply Contraction, Flat Demand, Full-Scale "Defense Priority"
-
South Korea and Japan Launch Energy Supply Chain Cooperation as Hormuz Risks Grow
-
Pakistan Launches Successive Anti-dumping Investigations against Chinese Products, Involving Soda Ash, Ibuprofen and Other Raw Materials
-
FDA Color Policy Uncertainty Opens a New Chapter for Food Ingredient Reform
-
FDA’s Warning to Compounders Raises the Stakes for API and Excipient Suppliers
-
FDA Lifts Administrative Stay, Restoring Red No. 3 Ban Timeline for Food and Ingested Drugs
-
Brazil Expands Chemical Tax Breaks as India’s Crop Protection Industry Warns of a 25% Cost Increase
-
After Semaglutide Patent Expiry in India, the Price System Has Been Restructured as More Than 40 Drugmakers Enter the Competition
-
South Korea’s Largest Petrochemical Hub Moves to Cut Cracker Capacity by 40%
-
China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
Recommend Reading
-
WACKER’s 2025 Loss Reaches €805 Million as the PACE Cost-Cutting Plan Becomes the Key Variable for 2026
-
EU Chemicals Regulatory Update: Practical Compliance Actions Following ECHA January 2026 Developments
-
Your Plant Has the Data. Your AI Cannot Reach It. Here Is Why That Is the Core Problem in Chemical Manufacturing.
-
FDA Dye Pledges Push Natural Colors Into the Mainstream
-
FDA Fee Updates Raise the Cost of Entering the U.S. Generic Drug Chain
-
Business Society Petroleum Coke Daily Review: Overall Downward Trend on August 7, 2026
-
Business Society’s Diesel Market Outlook on August 10, 2026: Volatile but Rising
-
July MTBE market price increase in China is significant
-
Business Society’s Market Outlook for Fuel Oil 180CST on August 10, 2026: Volatile
-
What Color Should a Zinc-Copper Couple Be?